Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and other respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.

Overall MarketRank^™

0.25 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Viemed Healthcare.

0.0 Community Rank

Outperform Votes
Viemed Healthcare has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Viemed Healthcare has received 1 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Viemed Healthcare has received 100.00% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Viemed Healthcare and other stocks. Vote “Outperform” if you believe VMD will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VMD will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Viemed Healthcare does not currently pay a dividend.
Dividend Growth
Viemed Healthcare does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Viemed Healthcare insiders have not sold or bought any company stock.

1.3 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Viemed Healthcare is 13.35, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.35.
Price to Earnings Ratio vs. Sector
The P/E ratio of Viemed Healthcare is 13.35, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 44.21.
Price to Book Value per Share Ratio
Viemed Healthcare has a P/B Ratio of 5.50. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Viemed Healthcare (TSE:VMD) Frequently Asked Questions

Is Viemed Healthcare a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viemed Healthcare in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" Viemed Healthcare stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in VMD, but not buy additional shares or sell existing shares.
View analyst ratings for Viemed Healthcare or view top-rated stocks.

What stocks does MarketBeat like better than Viemed Healthcare?

Wall Street analysts have given Viemed Healthcare a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Viemed Healthcare wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Viemed Healthcare's next earnings date?

Viemed Healthcare is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Viemed Healthcare.

How were Viemed Healthcare's earnings last quarter?

Viemed Healthcare, Inc. (TSE:VMD) issued its quarterly earnings data on Wednesday, March, 3rd. The company reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.09 by $0.07. The company had revenue of $40.67 million for the quarter, compared to analyst estimates of $41.50 million.
View Viemed Healthcare's earnings history.

Who are Viemed Healthcare's key executives?

Viemed Healthcare's management team includes the following people:

Mr. Casey Hoyt, CEO & Director (Age 44, Pay $1.13M)
Mr. Michael B. Moore, Pres (Age 43, Pay $1.03M)
Mr. Trae Paul Fitzgerald, Chief Financial Officer (Age 32, Pay $433k)
Mr. William Todd Zehnder, COO & Director (Age 46, Pay $1M)
Mr. Jerome Richard Cambre II, VP of Sales (Age 50, Pay $462.47k)
Dr. William Dana Frazier, Chief Medical Officer & Director (Age 63)
John Collier, Chief Technology Officer
Claudio Munoz, Chief Information Officer
Mr. Brett Stoute, Chief Compliance Officer
Rob Birkhead, Chief Marketing Officer

Who are some of Viemed Healthcare's key competitors?

Some companies that are related to Viemed Healthcare include Treace Medical Concepts (TMCI), Stratec (SBS), 908 Devices (MASS), Avacta Group (AVCT), Drägerwerk AG & Co. KGaA (DRW3), Neuropace (NPCE), Asensus Surgical (ASXC), Itamar Medical (ITMR), Creo Medical (CREO), Talis Biomedical (TLIS), Titan Medical (TMD), Medica Group (MGP), Polarean Imaging (POLX), Hamilton Thorne (HTL) and Xtant Medical (XTNT).
View all of VMD's competitors.

What is Viemed Healthcare's stock symbol?

Viemed Healthcare trades on the Toronto Stock Exchange (TSX) under the ticker symbol "VMD."

How do I buy shares of Viemed Healthcare?

Shares of VMD and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Viemed Healthcare's stock price today?

One share of VMD stock can currently be purchased for approximately C$11.60.

How much money does Viemed Healthcare make?

Viemed Healthcare has a market capitalization of C$459.10 million and generates C$135.92 million in revenue each year.

How many employees does Viemed Healthcare have?

Viemed Healthcare employs 511 workers across the globe.

What is Viemed Healthcare's official website?

The official website for Viemed Healthcare is www.viemed.com.

How can I contact Viemed Healthcare?

The company can be reached via phone at 337 504 3802.

This page was last updated on 5/8/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Viemed Healthcare Stock Forecast, Price & News

Adding

Adding

Adding Viemed Healthcare, Inc.

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Headlines

About Viemed Healthcare

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

0.0 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth

0.0 Company Ownership

Insider Buying vs. Insider Selling

1.3 Earnings and Valuation

Price to Earnings Ratio vs. the Market

Price to Earnings Ratio vs. Sector

Price to Book Value per Share Ratio